Siegel RL, KD M (2018) Cancer statistics, 2018. Ca Cancer J Clin 68(1):7

Article  PubMed  Google Scholar 

Yang F, Xu J, Tang L, Guan X (2016) Breast cancer stem cell: the roles and therapeutic implications. Cell Mol Life Sci 74(6):951–966

Article  PubMed  Google Scholar 

Nilendu P, Kumar A, Kumar A, Pal JK, Sharma NK Breast cancer stem cells as last soldiers eluding therapeutic burn: a hard nut to crack. Int J Cancer 2017, 142(1)

Garcia-Lavandeira M, Saez C, Diaz-Rodriguez E, Perez-Romero S, Senra A, Dieguez C, Japon MA, Alvarez CV (2012) Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors. J Clin Endocrinol Metab 97(1):E80–87

Article  CAS  PubMed  Google Scholar 

Cantile M, Collina F, D’Aiuto M, Rinaldo M, Pirozzi G, Borsellino C, Franco R, Botti G, Di Bonito M (2013) Nuclear localization of cancer stem cell marker CD133 in triple-negative breast cancer: a case report. Tumori 99(5):e245–250

Article  PubMed  Google Scholar 

Liu TJ, Sun BC, Zhao XL, Zhao XM, Sun T, Gu Q, Yao Z, Dong XY, Zhao N, Liu N (2013) CD133 + cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer. Oncogene 32(5):544–553

Article  CAS  PubMed  Google Scholar 

Hong D, Fritz AJ, Zaidi SK, Wijnen AJ, Nickerson JA, Imbalzano AN, Lian JB, Stein JL, Stein GS (2018) Epithelial-to‐mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity. J Cell Physiol 233(12):9136–9144

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wicha MS, Brooks M, Ming L (2015) Epithelial-mesenchymal plasticity of breast Cancer stem cells: implications for Metastasis and Therapeutic Resistance. Curr Pharm Design 21(10):–

Moon JS, Nakahira K, Choi AM (2015) Fatty acid synthesis and NLRP3-inflammasome. Oncotarget 6(26):21765–21766

Article  PubMed  PubMed Central  Google Scholar 

Schroder K, Zhou R, Tschopp J (2010) The NLRP3 inflammasome: a Sensor for Metabolic Danger? Science 327(5963):296–300

Article  CAS  PubMed  Google Scholar 

Wen H, Ting JP, O’Neill LA (2012) A role for the NLRP3 inflammasome in metabolic diseases–did Warburg miss inflammation? Nat Immunol 13(4):352–357

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Zhang JH, Chen XY, Hu QH, Wang MX, Jin R, Zhang QY, Wang W, Wang R, Kang LL (2015) ROS-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. 22(10):848–870

Jiang Q, Geng X, Warren J, Eugene Paul Cosky E, Kaura S, Stone C, Li F, Ding Y (2020) Hypoxia Inducible Factor-1α (HIF-1α) mediates NLRP3 inflammasome-dependent-pyroptotic and apoptotic cell death following ischemic stroke. Neuroscience 448:126–139

Article  CAS  PubMed  Google Scholar 

Zhu L, Meng Q, Liang S, Ma Y, Li R, Li G, Zeng H (2014) The transcription factor GFI1 negatively regulates NLRP3 inflammasome activation in macrophages. FEBS Lett 588(23):4513–4519

Article  CAS  PubMed  Google Scholar 

Wu S, Sun J, Vitamin D, Vitamin D (2011) Receptor, and Macroautophagy in inflammation and infection. Discov Med 11(59):325–335

PubMed  PubMed Central  Google Scholar 

Zheng J, Chang MR, Stites RE, Wang Y, Bruning JB, Pascal BD, Novick SJ, Garcia-Ordonez RD, Stayrook KR, Chalmers MJ et al (2017) HDX reveals the conformational dynamics of DNA sequence specific VDR co-activator interactions. Nat Commun 8(1):923

Article  PubMed  PubMed Central  Google Scholar 

Wang W, Zhao M, Cui L, Ren Y, Zhang J, Chen J, Jia L, Zhang J, Yang J, Chen G et al (2020) Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer. Mol Cancer 19(1):134

Article  PubMed  PubMed Central  Google Scholar 

Zheng W, Cao L, Ouyang L, Zhang Q, Duan B, Zhou W, Chen S, Peng W, Xie Y, Fan Q et al (2019) Anticancer activity of 1,25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway. Onco Targets Ther 12:721–732

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng W, Duan B, Zhang Q, Ouyang L, Peng W, Qian F, Wang Y, Huang S (2018) : Vitamin D-induced vitamin D receptor expression induces tamoxifen sensitivity in MCF-7 stem cells via suppression of Wnt/β-catenin signaling. Biosci Rep 38(6)

Bi C, Chadwick J, Davies ML, DelMonte A, Geng P, Glace A, Green R, Gurak JA, Haley MW, He BL et al (2023) Coupling-condensation strategy for the Convergent synthesis of an imidazole-fused 2-Aminoquinoline NLRP3 agonist. J Org Chem 88(1):384–394

Article  CAS  PubMed  Google Scholar 

Li W, Wang Y, Tang Y, Lu H, Qi Y, Li G, He H, Lu F, Yang Y, Sun H (2021) Quercetin alleviates osteoarthritis progression in rats by suppressing inflammation and apoptosis via inhibition of IRAK1/NLRP3 signaling. J Inflamm Res 14:3393–3403

Article  CAS  PubMed  PubMed Central  Google Scholar 

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego Calif) 25(4):402–408

Article  CAS  PubMed  Google Scholar 

Norton KA, Jin K, Popel AS (2018) : Modeling triple-negative breast cancer heterogeneity: effects of stromal macrophages, fibroblasts and tumor vasculature. J Theor Biol 452

Hildebolt CF, Pilgram TK, Dotson M, Armamento-Villareal R, Hauser J, Cohen S, Civitelli R (2017) Estrogen and/or calcium plus vitamin D increase Mandibular Bone Mass. 75(6):811–816

Hu K, Callen DF, Li J, Zheng H (2017) Circulating Vitamin D and overall survival in breast Cancer patients: a dose-response Meta-analysis of Cohort studies. Integr Cancer Ther 17(2):153473541771200

Google Scholar 

Li MX, Li LF, Zhang L, Xiao ZG, Shen J, Hu W, Zeng Q, Cho CH (2017) Vitamin D and Cancer stem cells in the gastrointestinal tract. Curr Med Chem 24(9):918–927

Article  CAS  PubMed  Google Scholar 

Mondul AM, Weinstein SJ, Layne TM, Albanes D (2017) Vitamin D and Cancer risk and mortality: state of the Science, gaps, and challenges. Epidemiol Rev 39(1):1–21

Article  Google Scholar 

Speers C, Brown P (2015) Breast Cancer Prevention using calcium and vitamin D: a Bright Future? 100(22):1562

So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, Maehr H, Uskokovic M, Zheng X, Conney AH, Cai L et al (2011) A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer. Mol Pharmacol 79(3):360–367

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hansson ME, Norlin AC, Omazic B, Wikstrom AC, Bergman P, Winiarski J, Remberger M, Sundin M (2014) Vitamin d levels affect outcome in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transpl 20(10):1537–1543

Article  CAS  Google Scholar 

Francesca P, Adriana DB, Graziana C, Giacomina AC-AE, Chiara B, Teresa P, Maria T, Giorgio G (2016) M: Vitamin D effects on Osteoblastic differentiation of mesenchymal stem cells from Dental tissues. Stem Cells Int, :1–9

Huang CF, Chen L, Li Y-C, Wu L, Yu G-T, Zhang W-F, Sun Z-J NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma. J Experimental Clin Cancer Res Cr, 36(1):116

Hu Q, Zhao F, Guo F, Wang C, Fu Z Polymeric nanoparticles induce NLRP3 inflammasome activation and promote breast Cancer metastasis. Macromol Biosci :1700273

Huang H, Hong JY, Wu YJ, Wang EY, Liu ZQ, Cheng BH, Mei L, Liu ZG, Yang PC, Zheng PY (2018) Vitamin D receptor interacts with NLRP3 to restrict the allergic response. Clin Exp Immunol 194(1):17–26

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nunes PR, Romao-Veiga M, Matias ML, Ribeiro VR, de Oliveira L, Peracoli JC, Terezinha SPM (2022) Vitamin D decreases expression of NLRP1 and NLRP3 inflammasomes in placental explants from women with preeclampsia cultured with hydrogen peroxide. Hum Immunol 83(1):74–80

Article  CAS  PubMed  Google Scholar 

Wu M, Lu L, Guo K, Lu J, Chen H (2022) Vitamin D protects against high glucose-induced pancreatic β-cell dysfunction via AMPK-NLRP3 inflammasome pathway. Mol Cell Endocrinol 547:111596

Article  CAS  PubMed  Google Scholar